Multiple Myeloma DiagnosisExplore This Section Doctors sometimes find multiple myeloma after a routine blood test. More often, doctors suspect multiple myeloma after an x-ray for a broken bone. Usually though, patients go to the doctor because they are having other symptoms. To find out whether ...
Multiple Myeloma Diagnosis Doctors sometimes find multiple myeloma after a routine blood test. More often, doctors suspect multiple myeloma after an x-ray for a broken bone. Usually though, patients go to the doctor because they are having other symptoms. ...
Multiple myeloma, also known as Kahler's disease, is a type of blood cancer. There's no cure, but treatments can slow its spread and sometimes make symptoms go away. A type of white blood cell called a plasma cell makes antibodies that fight infections in your body. When you have multi...
This is a comprehensive, state-of-the-art guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. Edited and written by a multidisciplinary group of recognized authorities from the Mayo Clinic, it presents clear guidelines on diagnosis and therapy and covers...
Patients with multiple myeloma often experience long diagnostic delay, with 50% of the patients' experience delay longer than 3 months. Prompt establishment of the source of pain and paresthesia is crucial. Early diagnosis and management limit the disease process, help to reduce the associated ...
Immunofixation, also called immunoelectrophoresis (IFE):If a problem protein is found by the SPEP test, your doctor may use this blood test to learn more about it. That can help you find out what type of immunoglobulins are involved with the myeloma. ...
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.
Multiple myeloma is the second most common hematologic malignancy. In Multiple myeloma a serum or urine monoclonal component is produced by bone marrow plasma cells. Great progresses have been made in the latest 10 years and survivals are nearly doubled. This improvement has been reached with novel...
Multiple myeloma (MM) is a highly heterogenous disease that exists along a continuous disease spectrum starting with premalignant conditions monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) that inevitably precede MM. Over the past two decades, significant pro...
3). To mimic the clinical scenario of MM diagnosis, once MM reaches 10% of the bone marrow area in silico, treatment is applied either continuously (as for mouse models of multiple myeloma) or pulsed (2 weeks on, 1 week off; as is performed in the clinic) until MM burden reaches 20...